이제 jnjmedtech.com을 나가게 됩니다. '계속'을 클릭하면 자체적인 법적 고지 및 개인정보 처리방침을 따르는 웹사이트로 이동하게 됩니다.
References
‡ 21 RCTs, 6462 patients, 95% CI: (14, 40%), P<0.001.
§All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL® Plus Antibacterial [poliglecaprone 25] Suture, Coated VICRYL® Plus Antibacterial [polyglactin 910] Suture, and PDS® Plus Antibacterial [polydioxanone] Suture).
1. de Jonge SW, Atema JJ, Solomkin JS, Boermeester MA. Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg. 2017;104(2):e118-e133.
2. Clean wounds 10 RCT, 2842 patients 95% CI (11-43%). P= 0.003; non-clean wounds 14 RCT, 3620 patients. 95% CI (7 – 42%).
3. Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt). 2002;3 Suppl 1:S79-S87.
4. Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial eicacy of PDS plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt). 2008;9(4):451-457
5. Ming X, Rothenburger S, Yang D. In vitro antibacterial eicacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). Surg Infect (Larchmt). 2007;8(2):201-208.